SPG11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.465000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.579400E-01
Normal-vs-Stage2
4.649400E-01
Normal-vs-Stage3
9.947700E-02
Normal-vs-Stage4
5.162000E-01
Stage1-vs-Stage2
5.664600E-01
Stage1-vs-Stage3
6.205000E-03
Stage1-vs-Stage4
7.562600E-01
Stage2-vs-Stage3
3.116200E-02
Stage2-vs-Stage4
8.076600E-01
Stage3-vs-Stage4
2.035700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.469000E-01
Normal-vs-AfricanAmerican
2.550600E-01
Normal-vs-Asian
2.940200E-01
Caucasian-vs-AfricanAmerican
8.763200E-01
Caucasian-vs-Asian
9.730800E-01
AfricanAmerican-vs-Asian
9.495200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.283600E-01
Normal-vs-Female
4.681800E-01
Male-vs-Female
4.128400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.895000E-01
Normal-vs-Age(41-60Yrs)
4.780800E-01
Normal-vs-Age(61-80Yrs)
4.284600E-01
Normal-vs-Age(81-100Yrs)
4.327800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.380400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.723200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.039000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.265800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.611600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.911000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.762400E-01
Normal-vs-Daily Drinker
1.502590E-01
Normal-vs-Weekly Drinker
7.242400E-02
Normal-vs-Occasional Drinker
4.829400E-01
Normal-vs-Social Drinker
4.357000E-01
Non Drinker-vs-Daily Drinker
7.329400E-01
Non Drinker-vs-Weekly Drinker
1.461970E-01
Non Drinker-vs-Occasional Drinker
9.450200E-01
Non Drinker-vs-Social Drinker
6.690000E-01
Daily Drinker-vs-Weekly Drinker
3.386600E-01
Daily Drinker-vs-Occasional Drinker
7.090000E-01
Daily Drinker-vs-Social Drinker
9.579200E-01
Weekly Drinker-vs-Occasional Drinker
1.354630E-01
Weekly Drinker-vs-Social Drinker
2.921600E-01
Occasional Drinker-vs-Social Drinker
5.931400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.360400E-02
Normal-vs-Grade 2
4.595100E-04
Normal-vs-Grade 3
4.244500E-04
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.503600E-02
Grade 1-vs-Grade 3
8.843600E-02
Grade 1-vs-Grade 4
2.360400E-02
Grade 2-vs-Grade 3
7.712400E-01
Grade 2-vs-Grade 4
4.595100E-04
Grade 3-vs-Grade 4
4.244500E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.868800E-01
Normal-vs-NonDiabetic
4.644000E-01
Diabetic-vs-NonDiabetic
1.577370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.778600E-01
Normal-vs-NoPancreatitis
4.440800E-01
Pancreatitis-vs-NoPancreatitis
2.414400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.225800E-01
Normal-vs-N1
4.680600E-01
N0-vs-N1
3.872200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.185200E-01
Normal-vs-TP53-NonMutant
4.899600E-01
TP53-Mutant-vs-TP53-NonMutant
1.123040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
